Leslie W. Kreis insider trades
Open-market stock purchases and sales by Leslie W. Kreis, Director, 10% Owner at Actuate Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2020.
Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -88%.
Recent trades
No open-market trades in the last 12 months.